Cargando…
TAS‐116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T‐cell leukemia
Adult T‐cell leukemia/lymphoma (ATL) is a highly chemoresistant malignancy of peripheral T lymphocytes caused by human T‐cell leukemia virus type 1 infection, for which there is an urgent need for more effective therapeutic options. The molecular chaperone heat shock protein 90 (HSP90) plays a cruci...
Autores principales: | Ikebe, Emi, Shimosaki, Shunsuke, Hasegawa, Hiroo, Iha, Hidekatsu, Tsukamoto, Yoshiyuki, Wang, Yu, Sasaki, Daisuke, Imaizumi, Yoshitaka, Miyazaki, Yasushi, Yanagihara, Katsunori, Hamaguchi, Isao, Morishita, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819293/ https://www.ncbi.nlm.nih.gov/pubmed/34794206 http://dx.doi.org/10.1111/cas.15204 |
Ejemplares similares
-
Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
por: Suzuki, Rikio, et al.
Publicado: (2014) -
Antiobesity and Anti-Inflammatory Effects of Orally Administered Bonito Extracts on Mice Fed a High-Fat Diet
por: Ikebe, Emi, et al.
Publicado: (2017) -
Optimizing antidotal treatment with the oral HSP90 inhibitor TAS-116 against hydrochloric acid-induced pulmonary fibrosis in mice
por: Solopov, Pavel A., et al.
Publicado: (2022) -
Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia–lymphoma cells
por: Taniguchi, Hiroaki, et al.
Publicado: (2014) -
TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells
por: Ranta-aho, Sofia, et al.
Publicado: (2021)